San Francisco Business Times (blog) ... product record review and the company's process for inspecting the failure of some manufacturing batches to meet specifications. Those inspections led Impax to recall five lots of its 200-milligram generic version of the cholesterol-fighting drug ... and more »
DigitalJournal.com (press release) Mylan Inc. (Nasdaq:MYL) recently announced the launch of its generic version of AbbVie Inc.'s (NYSE:ABBV) cholesterol management drug, TriCor ( fenofibrate , 48 mg and 145 mg tablets). Mylan launched the drug after receiving final approval from the US ... and more »
Business Standard On Friday, Mylan Inc in a statement said that its subsidiary Mylan Pharmaceuticals Inc has shipped generic Tricor, or fenofibrate tablets, of 48 mg a...
Economic Times Mylan Inc said in a statement on Friday that its unit Mylan Pharmaceuticals Inc has shipped generic Tricor, or fenofibrate tablets, of 48 mg and 145 mg. Mylan competes against Lupin, which also sells generic versions of Tricor. Credit Suisse said that ...
Moneycontrol.com Lupin falls; Mylan launches cholesterol drug. Mylan Inc said in a statement on Friday its unit Mylan Pharmaceuticals Inc has shipped generic Tricor, or fenofibrate tablets, of 48 mg and 145 mg. Mylan compete against Lupin, which also sells generic ...
Business Standard Shares of Lupin Ltd have plunged by 4.5% on BSE following the launch of rival Mylan Inc's generic version of the cholesterol-lowering Tricor ( Fenofibrate ) tablets. On Monday, Lupin's shares were closed at Rs 768.05 on BSE. Also, Credit Suisse has ...
Pittsburgh Business Times Mylan Pharmaceuticals has started shipping fenofibrate tablets in two strengths after receiving final approval from the Food and Drug Administration, the Canonsburg company announced. Fenofibrate is the generic version of AbbVie Inc.'s Tricor, which is ...
PR Newswire (press release) Mylan Inc. (Nasdaq: MYL) recently announced the launch of its generic version of AbbVie Inc.'s (NYSE: ABBV) cholesterol management drug, TriCor ( fenofibrate , 48 mg and 145 mg tablets). Mylan launched the drug after receiving final approval from the US ... and more »
